19-03-2012

CSL Behring announced that the first patient has been treated as part of the REPLACE Phase III clinical trial evaluating the efficacy and safety of fibrinogen concentrate (Human) (FCH) in controlling microvascular bleeding during aortic aneurysm surgery.The purpose of this study is to ...

more

04-06-2010

Endotis Pharma presented that initial results on the neutralizable anticoagulant EP217609 in a canine model of extracorporeal circulation (ECC) at the French Society of Thoracic and Cardiovascular Surgery's 63th annual meeting in Tours, France. Both EP217609 and its specific antidote avidin ...

more

20-03-2007

SR Pharma plc announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug application (IND) for a second siRNA therapeutic which is based on the company 's unique proprietary chemistry. The product is AKIi-5, which is being developed by Quark Biotech ...

more

05-03-2007

Med BioGene Inc. announced that it has appointed Dr. Richard C. Cook, MD, M.Sc., FRCSC, to its Scientific Advisory Board. Dr. Cook is a Clinical Associate Professor of Surgery with the Department of Cardiovascular Surgery at the University of British Columbia and is an expert in complex ...

more